The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
-
Published:2012-06
Issue:9834
Volume:379
Page:2352-2363
-
ISSN:0140-6736
-
Container-title:The Lancet
-
language:en
-
Short-container-title:The Lancet
Reference35 articles.
1. Preventing stroke: saving lives around the world;Strong;Lancet Neurol,2007
2. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study);Rothwell;Lancet,2004
3. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review;Feigin;Lancet Neurol,2009
4. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data;Lopez;Lancet,2006
5. Trends in incidence and outcome of stroke in Perth, Western Australia during 1989 to 2001: the Perth Community Stroke Study;Islam;Stroke,2008
Cited by
1027 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献